DiscussionInvited Perspective
PET of αvβ3-Integrin and αvβ5-Integrin Expression with 18F-Fluciclatide for Assessment of Response to Targeted Therapy: Ready for Prime Time?
Ambros J. Beer and Markus Schwaiger
Journal of Nuclear Medicine February 2011, jnumed.110.078568; DOI: https://doi.org/10.2967/jnumed.110.078568
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
PET of αvβ3-Integrin and αvβ5-Integrin Expression with 18F-Fluciclatide for Assessment of Response to Targeted Therapy: Ready for Prime Time?
Ambros J. Beer, Markus Schwaiger
Journal of Nuclear Medicine Feb 2011, jnumed.110.078568; DOI: 10.2967/jnumed.110.078568